Literature DB >> 14986783

Informed consent and the use of placebo in Poland: ethical and legal aspects.

Piotr Zaborowski1, Adam Górski.   

Abstract

The concept of informed consent was one of the most fruitful ideas that deeply changed the relationships between physicians and their patients from paternalism to respect for the personal autonomy of subjects needing professional medical care. The great progress in medicine, also involving the pharmaceutical industry, has created an increasing need to perform different clinical and experimental trials. The evolution of clinical research in the last decades has influenced strongly the design of these studies. One of the most important changes in this field has been the use of placebo groups in double-blind controlled studies. The controversies have involved not only the use of placebo when standard or proven treatment was available, but also some specific problems concerning the procedure of obtaining informed consent in such trials. This paper briefly presents the evolution of informed consent in Poland as well as different ethical and legal problems concerning informed consent and the use of placebo controls in clinical trials.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Substances:

Year:  2004        PMID: 14986783     DOI: 10.1007/s11948-004-0074-9

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  20 in total

1.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Ethical issues in the design and conduct of clinical trials in developing countries.

Authors:  H T Shapiro; E M Meslin
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

3.  The better-than-nothing idea: debating the use of placebo controls.

Authors: 
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

4.  The uncertainty principle and industry-sponsored research.

Authors:  B Djulbegovic; M Lacevic; A Cantor; K K Fields; C L Bennett; J R Adams; N M Kuderer; G H Lyman
Journal:  Lancet       Date:  2000-08-19       Impact factor: 79.321

5.  Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.

Authors:  S S Ellenberg; R Temple
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

6.  Continued need for placebo in many cases, even when there is effective therapy.

Authors:  Robert J Temple; Robert Meyer
Journal:  Arch Intern Med       Date:  2003-02-10

7.  Informed consent from whom?

Authors:  D Mulcahy; K Cunningham; D McCormack; N Cassidy; M Walsh
Journal:  J R Coll Surg Edinb       Date:  1997-06

8.  Patient advocacy in the 1990s.

Authors:  B Weston; M Lauria
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

9.  The continuing unethical use of placebo controls.

Authors:  K J Rothman; K B Michels
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

10.  The power of compassion: truth-telling among American doctors in the care of dying patients.

Authors:  N T Miyaji
Journal:  Soc Sci Med       Date:  1993-02       Impact factor: 4.634

View more
  1 in total

Review 1.  Placebo: its action and place in health research today--summary and conclusions.

Authors:  Raymond E Spier
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.